Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
SNDX
FDA Approves Syndax's Revuforj for r/r Acute Leukemia
| 2024-11-18 |
PHARMACEUTICAL
Syndax Pharmaceuticals Reports $209.4M Net Loss in Recent 10-K
| 2024-02-28 |
PHARMACEUTICAL
